Overview
Jonathan Kurie is a primary care provider, practicing in Internal Medicine in Cary, North Carolina.
Dr. Kurie is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Lung Adenocarcinoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).
He is actively involved in clinical research, co-authoring 87 peer reviewed articles and participating in 1 clinical trial.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
Locations
210 Ashville Ave # 408, Cary, NC 27518
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
UT MD Anderson Cancer Center
Jan Burger is a primary care provider, practicing in Internal Medicine in Cary, North Carolina. Dr. Burger is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, Bone Marrow Aspiration, and Angioplasty.
UT MD Anderson Cancer Center
Guillermo Montalban-Bravo is a primary care provider, practicing in Internal Medicine in Cary, North Carolina. Dr. Montalban-Bravo is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML), Leukemia, and Bone Marrow Aspiration.
UT MD Anderson Cancer Center
Stacy Moulder is a primary care provider, practicing in Internal Medicine in Cary, North Carolina. Dr. Moulder is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Triple-Negative Breast Cancer, Breast Cancer, PIK3CA-Related Overgrowth Spectrum, and HER-2 Positive Breast Cancer.
Frequently Asked Questions about Dr. Jonathan M. Kurie
How do I make an appointment with Dr. Jonathan M. Kurie?
You can book an appointment with Dr. Jonathan M. Kurie by calling their office at 713-792-6161. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jonathan M. Kurie a top-rated expert for Lung Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jonathan M. Kurie is classified as an Elite expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jonathan M. Kurie specialize in?
While Dr. Jonathan M. Kurie is a Internal Medicine, they have specific expertise in Lung Adenocarcinoma, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.
Does Dr. Jonathan M. Kurie participate in research or clinical trials?
Yes. Dr. Jonathan M. Kurie has published 87 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Dr. Jonathan M. Kurie's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Jonathan M. Kurie accept my insurance?
Dr. Jonathan M. Kurie accepts most major insurance plans, including Blue Cross Blue Shield and Humana. We recommend calling the office directly at 713-792-6161 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung AdenocarcinomaDr. Kurie isElite. Learn about Lung Adenocarcinoma.
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Kurie isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Lung CancerDr. Kurie isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Kurie isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Small Cell Lung Cancer (SCLC)Dr. Kurie isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Kurie isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- EGFR Positive Lung CancerDr. Kurie isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung MetastasesDr. Kurie isAdvanced. Learn about Lung Metastases.
- Experienced
- Metastatic Pleural TumorDr. Kurie isExperienced. Learn about Metastatic Pleural Tumor.
- Neuroendocrine TumorDr. Kurie isExperienced. Learn about Neuroendocrine Tumor.
- Thymic Epithelial TumorDr. Kurie isExperienced. Learn about Thymic Epithelial Tumor.